Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks

Research output: Contribution to journalReviewResearchpeer-review

Standard

Clinical Pharmacopsychology : Conceptual Foundations and Emerging Tasks. / Fava, Giovanni A.; Tomba, Elena; Bech, Per.

In: Psychotherapy and Psychosomatics, Vol. 86, No. 3, 05.2017, p. 134-140.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Fava, GA, Tomba, E & Bech, P 2017, 'Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks', Psychotherapy and Psychosomatics, vol. 86, no. 3, pp. 134-140. https://doi.org/10.1159/000458458

APA

Fava, G. A., Tomba, E., & Bech, P. (2017). Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks. Psychotherapy and Psychosomatics, 86(3), 134-140. https://doi.org/10.1159/000458458

Vancouver

Fava GA, Tomba E, Bech P. Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks. Psychotherapy and Psychosomatics. 2017 May;86(3):134-140. https://doi.org/10.1159/000458458

Author

Fava, Giovanni A. ; Tomba, Elena ; Bech, Per. / Clinical Pharmacopsychology : Conceptual Foundations and Emerging Tasks. In: Psychotherapy and Psychosomatics. 2017 ; Vol. 86, No. 3. pp. 134-140.

Bibtex

@article{a61a6d3bd812460ab463f492adf337d6,
title = "Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks",
abstract = "The aim of this critical review was to outline emerging trends and perspectives of clinical pharmacopsychology, an area of clinical psychology that is concerned with the psychological effects of medications. The historical development of clinical pharmacopsychology is outlined, with discussion of its most representative expressions and reference to current challenges of clinical research, with particular reference to clinimetrics. The domains of clinical pharmacopsychology encompass the clinical benefits of psychotropic drugs, the characteristics that predict responsiveness to treatment, the vulnerabilities induced by treatment (side effects, behavioral toxicity, iatrogenic comorbidity), and the interactions between drug treatment and psychological variables. Its aim is to provide a comprehensive assessment of the clinical important changes that are concerned with (a) wanted and expected treatment effects, (b) treatment-induced unwanted side effects, and (c) the patient's own personal experience of a change in terms of well-being and/or quality of life. Clinical pharmacopsychology offers a unifying framework for the understanding of clinical phenomena in medical and psychiatric settings. Research in this area deserves high priority.",
keywords = "Behavioral toxicity, Clinical pharmacopsychology, Clinical psychology, Clinimetrics, Iatrogenic comorbidity, Psychotherapy, Rating scales",
author = "Fava, {Giovanni A.} and Elena Tomba and Per Bech",
year = "2017",
month = may,
doi = "10.1159/000458458",
language = "English",
volume = "86",
pages = "134--140",
journal = "Psychotherapy and Psychosomatics",
issn = "0033-3190",
publisher = "S Karger AG",
number = "3",

}

RIS

TY - JOUR

T1 - Clinical Pharmacopsychology

T2 - Conceptual Foundations and Emerging Tasks

AU - Fava, Giovanni A.

AU - Tomba, Elena

AU - Bech, Per

PY - 2017/5

Y1 - 2017/5

N2 - The aim of this critical review was to outline emerging trends and perspectives of clinical pharmacopsychology, an area of clinical psychology that is concerned with the psychological effects of medications. The historical development of clinical pharmacopsychology is outlined, with discussion of its most representative expressions and reference to current challenges of clinical research, with particular reference to clinimetrics. The domains of clinical pharmacopsychology encompass the clinical benefits of psychotropic drugs, the characteristics that predict responsiveness to treatment, the vulnerabilities induced by treatment (side effects, behavioral toxicity, iatrogenic comorbidity), and the interactions between drug treatment and psychological variables. Its aim is to provide a comprehensive assessment of the clinical important changes that are concerned with (a) wanted and expected treatment effects, (b) treatment-induced unwanted side effects, and (c) the patient's own personal experience of a change in terms of well-being and/or quality of life. Clinical pharmacopsychology offers a unifying framework for the understanding of clinical phenomena in medical and psychiatric settings. Research in this area deserves high priority.

AB - The aim of this critical review was to outline emerging trends and perspectives of clinical pharmacopsychology, an area of clinical psychology that is concerned with the psychological effects of medications. The historical development of clinical pharmacopsychology is outlined, with discussion of its most representative expressions and reference to current challenges of clinical research, with particular reference to clinimetrics. The domains of clinical pharmacopsychology encompass the clinical benefits of psychotropic drugs, the characteristics that predict responsiveness to treatment, the vulnerabilities induced by treatment (side effects, behavioral toxicity, iatrogenic comorbidity), and the interactions between drug treatment and psychological variables. Its aim is to provide a comprehensive assessment of the clinical important changes that are concerned with (a) wanted and expected treatment effects, (b) treatment-induced unwanted side effects, and (c) the patient's own personal experience of a change in terms of well-being and/or quality of life. Clinical pharmacopsychology offers a unifying framework for the understanding of clinical phenomena in medical and psychiatric settings. Research in this area deserves high priority.

KW - Behavioral toxicity

KW - Clinical pharmacopsychology

KW - Clinical psychology

KW - Clinimetrics

KW - Iatrogenic comorbidity

KW - Psychotherapy

KW - Rating scales

U2 - 10.1159/000458458

DO - 10.1159/000458458

M3 - Review

C2 - 28490035

AN - SCOPUS:85018692497

VL - 86

SP - 134

EP - 140

JO - Psychotherapy and Psychosomatics

JF - Psychotherapy and Psychosomatics

SN - 0033-3190

IS - 3

ER -

ID: 189150527